Schipper L F, Brand A, Reniers N C, Melief C J, Willemze R, Fibbe W E
Red Cross Blood Bank Leidsenhage, The Netherlands.
Br J Haematol. 1998 Jun;101(3):425-35. doi: 10.1046/j.1365-2141.1998.00737.x.
Thrombopoietin (TPO) is considered to be the primary growth factor for regulating megakaryopoiesis and thrombopoiesis. In this study we investigated the in vitro effect of TPO on relatively immature and mature CD34+ progenitor cells in cord blood. Cells were cultured in both liquid and semi-solid cultures containing 50 ng/ml TPO. The CD34+/CD45RA- and CD34+/CD38- subfractions in cord blood were both enriched for megakaryocyte progenitors as determined in a semisolid CFU-meg assay. Progenitor cells derived from the CD34+/CD45RA- and CD34+/CD38- subfractions showed high proliferative capacity in liquid cultures. We observed a mean 19-fold expansion of the total CD34+ cell fraction, whereas in the CD34+/CD45RA- and CD34+/CD38- subfractions the mean expansion was 23- and 50-fold respectively. The expansion of the immature progenitor cell subfractions resulted in a highly purified megakaryocyte suspension containing > 80% megakaryocytes after 14 d in culture. However, these expanded megakaryocytes remained in a diploid (2N) and tetraploid (4N) state. Maturation could not be further induced by low concentration of TPO (0.1 ng/ml). The majority of the cells were 2N (80%) and 4N (15%) and only 5% of the cells had a ploidy of more than 4N. These results indicate that megakaryocyte progenitor cells in cord blood residing in the immature stem cell fraction exhibit a high proliferative capacity when cultured in the presence of TPO as the single growth factor, without maturation to hyperploid megakaryocytes.
血小板生成素(TPO)被认为是调节巨核细胞生成和血小板生成的主要生长因子。在本研究中,我们调查了TPO对脐带血中相对不成熟和成熟的CD34+祖细胞的体外作用。细胞在含有50 ng/ml TPO的液体和半固体培养基中培养。在半固体CFU-巨核细胞测定中确定,脐带血中的CD34+/CD45RA-和CD34+/CD38-亚组分均富含巨核细胞祖细胞。源自CD34+/CD45RA-和CD34+/CD38-亚组分的祖细胞在液体培养中显示出高增殖能力。我们观察到总CD34+细胞组分平均扩增了19倍,而在CD34+/CD45RA-和CD34+/CD38-亚组分中,平均扩增分别为23倍和50倍。不成熟祖细胞亚组分的扩增导致培养14天后产生了一种高度纯化的巨核细胞悬液,其中巨核细胞含量>80%。然而,这些扩增的巨核细胞仍处于二倍体(2N)和四倍体(4N)状态。低浓度TPO(0.1 ng/ml)无法进一步诱导其成熟。大多数细胞为2N(80%)和4N(15%),只有5%的细胞倍性超过4N。这些结果表明,当以TPO作为单一生长因子进行培养时,脐带血中存在于不成熟干细胞组分中的巨核细胞祖细胞具有高增殖能力,但不会成熟为超倍体巨核细胞。